Evidence map›Paper›PMID 39992711›Full record

ArticleeLife2025

Endosomal chemokine receptor signalosomes regulate central mechanisms underlying cell migration.

Hyunggu Hahn, Carole Daly, John Little, Nicole A Perry-Hauser, Emmanuel Flores-Espinoza, Asuka Inoue, Bianca Plouffe, Alex R B Thomsen

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. The spleen-brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  3. Article
  4. Article
  5. GPCR Biased Signaling in Cancer.Handbook of experimental pharmacology · 2026
    Review
  6. Review
  7. Article
  8. RABEP1 amplifies front signaling in neutrophil migration.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Beneath the surface: endosomal GPCR signaling.Trends in biochemical sciences · 2024
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyunggu Hahn *Department of Molecular Pathobiology, New York University College of Dentistry, New York, United States.ORCID https://orcid.org/0000-0003-3532-7671
Carole Daly *Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.
John Little *Department of Molecular Pathobiology, New York University College of Dentistry, New York, United States.
Nicole A Perry-HauserDepartment of Surgery, Columbia University Columbia University Vagelos College of Physicians and Surgeons, New York, United States.ORCID https://orcid.org/0000-0003-3130-3023
Emmanuel Flores-EspinozaDepartment of Molecular Pathobiology, New York University College of Dentistry, New York, United States.ORCID https://orcid.org/0000-0002-7889-7458
Asuka InoueGraduate School of Pharmaceutical Science, Tohoku University, Sendai, Japan.ORCID https://orcid.org/0000-0003-0805-4049
Bianca PlouffeWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.ORCID https://orcid.org/0000-0002-8321-0796
Alex R B ThomsenDepartment of Molecular Pathobiology, New York University College of Dentistry, New York, United States.ORCID https://orcid.org/0000-0003-1638-8911

Funding

Spatiotemporal Regulation of GPCR Signaling by Different Beta-Arrestin ConformationsR35GM147088 · NIGMS · NEW YORK UNIVERSITY · PI Alex Rojas Bie Thomsen · 2022 to 2026
$2.0M
Regulation of Melanoma Cell Malignancy by Compartmentalized Chemokine Receptor SignalingR21CA243052 · NCI · NEW YORK UNIVERSITY · PI THOMSEN, ALEX ROJAS BIE · 2022 to 2022
$413k
Biotechnology and Biological Sciences Research Council BB/X002578/1Japan Science and Technology Agency 10.52926/JPMJFR215TJapan Science and Technology Agency 10.52926/JPMJMS2023Japan Society for the Promotion of Science JP21H04791Japan Society for the Promotion of Science JP21H05113Japan Society for the Promotion of Science JP24K21281Japan Society for the Promotion of Science JPJSBP120213501Japan Society for the Promotion of Science JPJSBP120218801LEO Fondet LF18043NCI NIH HHS R21 CA243052NCI NIH HHS R21CA243052NIGMS NIH HHS R35 GM147088NIGMS NIH HHS R35GM147088Wellcome TrustWellcome Trust 10.35802/215229
6 · The paper itself

Abstract

Chemokine receptors are GPCRs that regulate the chemotactic migration of a wide variety of cells including immune and cancer cells. Most chemokine receptors contain features associated with the ability to stimulate G protein signaling during β-arrestin-mediated receptor internalization into endosomes. As endosomal signaling of certain non-GPCR receptors plays a major role in cell migration, we chose to investigate the potential role of endosomal chemokine receptor signaling on mechanisms governing this function. Applying a combination of pharmacological and cell biological approaches, we demonstrate that the model chemokine receptor CCR7 recruits G protein and β-arrestin simultaneously upon chemokine stimulation, which enables internalized receptors to activate G protein from endosomes. Furthermore, spatiotemporal-resolved APEX2 proteome profiling shows that endosomal CCR7 uniquely enriches specific Rho GTPase regulators as compared to plasma membrane CCR7, which is directly associated with enhanced activity of the Rho GTPase Rac1 and chemotaxis of immune T cells. As Rac1 drives the formation of membrane protrusions during chemotaxis, our findings suggest an important integrated function of endosomal chemokine receptor signaling in cell migration.

Indexed as

Cell MovementEndosomesReceptors, CCR7Signal Transductionbeta-ArrestinsChemotaxisHumansrac1 GTP-Binding Proteinbeta-ArrestinsCCR7 protein, humanrac1 GTP-Binding ProteinReceptors, CCR7CCR7cell biologychemokine receptorchemotaxisendosomal signalinghumanspatiotemporal-resolved proteomics

Identifiers

PMID39992711
PMCPMC11850004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.